Frontlight ResearchEarly access
Schizophrenia trials in United States
164 of 179 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStudy to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
- Where
- Atlanta, Bellflower, Culver City, Decatur, Gaithersburg, Garden Grove, Hallandale, Hollywood, Marlton, New York, Richardson, Riverside, Tampa
- Age
- 18 years to 55 years
- People
- 380
- Run by
- Minerva Neurosciences
See details and how to joinNCT07565428 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Where
- Alexandria, Anaheim, Augusta, Austin, Bellevue, Boca Raton, Dayton, Deerfield Beach, Denver, Doral, Homestead, Independence, Las Vegas, Long Beach, McKinney, Miami, Miami Gardens, Murrieta, Naples, New York, Orange, Orlando, Phoenix, Port Royal, Redlands, San Diego, Scottsdale, Snellville, Sugarland, Tampa, Tigard, Tucson, West Long Branch, West Palm Beach
- Age
- 55 years to 90 years
- People
- 300 worldwide
- Run by
- MapLight Therapeutics
See details and how to joinNCT06887192 · EU 2024-519820-26-00 - No phaseTaking peopleFAmily Engagement Strategy for Coordinated Specialty Care
- Where
- Bend, Pasco, Tacoma, Yakima
- Age
- 18 years and over
- People
- 450
- Run by
- Washington State University
See details and how to joinNCT06945055 - Phase 3SuspendedEvenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
- Where
- Atlanta, Baltimore, Los Angeles, Miami, New York
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Newron Pharmaceuticals SPA
See details and how to joinNCT07184619 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Where
- Anaheim, Atlanta, Boston, Chicago, Chino, Cincinnati, Culver City, Garland, Great Neck, Hollywood, Houston, Lawrenceville, Nashville, Neptune City, Orlando, Plano, Richmond, San Francisco, Spring, Stone Mountain
- Age
- 13 years to 17 years
- People
- 166 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07288567 · EU 2025-523711-11-00 - Phase 2Enrolling by invitationAn Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
- Where
- Anaheim, Denver, Doral, Independence, Miami, Miami Gardens, Orlando, Snellville
- Age
- 55 years to 91 years
- People
- 210 worldwide
- Run by
- MapLight Therapeutics
See details and how to joinNCT07459660 · EU 2025-521757-16-00 - Phase 4Taking peopleA Study to Evaluate the Effect of KarXT on Urological Safety
- Where
- Austin, Bellflower, Boynton Beach, Chicago, Chino, DeSoto, Garden Grove, Las Vegas, Lauderhill, Little Rock, Marlton, Orange, Philadelphia, Torrance, West Covina
- Age
- 18 years to 65 years
- People
- 60
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07221877 - Phase 2Taking peopleConfirmatory Trial of Gamma Neurofeedback to Improve Working Memory in Schizophrenia
- Where
- La Jolla
- Age
- 18 years to 55 years
- People
- 104
- Run by
- University of California, San Diego
See details and how to joinNCT07592169 - Phase 4Not yet taking people in United StatesHigher-Dose Maintenance With ERZOFRI 351 mg in Adults With Schizophrenia
- Where
- Chicago, Miami, Orange
- Age
- 18 years to 65 years
- People
- 40
- Run by
- Alejandro Alva
See details and how to joinNCT07927946 - No phaseTaking peopleCognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
- Where
- Baltimore, Chicago, Irvine, Minneapolis, St Louis
- Age
- 18 years to 59 years
- People
- 325
- Run by
- Washington University School of Medicine
See details and how to joinNCT07853807 - No phaseNot yet taking people in United StatesCognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2
- Where
- Baltimore, Chicago, Irvine, Minneapolis, St Louis
- Age
- 18 years to 59 years
- People
- 325
- Run by
- Washington University School of Medicine
See details and how to joinNCT07875790 - No phaseTaking peopleCognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 3
- Where
- Minneapolis, St Louis
- Age
- 18 years to 59 years
- People
- 10,000
- Run by
- Washington University School of Medicine
See details and how to joinNCT07900893 - Phase 1Taking peopleA Study to Assess the Safety, Tolerability and Pharmacokinetics of XEP527 in Patients With Stable Schizophrenia
- Where
- Bentonville
- Age
- 18 years to 65 years
- People
- 36
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07908680 - Phase 3Taking peopleA Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Where
- Anaheim, Atlanta, Bloomfield Hills, Boca Raton, Boston, Chicago, Chino, Cincinnati, Columbia, Culver City, Dallas, Danville, Decatur, Dothan, Everett, Gainesville, Garland, Glendale, Great Neck, Hollywood, Houston, Las Vegas, Lawrenceville, Lexington, Lincoln, Los Angeles, Louisville, Nashville, Neptune City, New Haven, Orange, Orangeburg, Orem, Orlando, Phoenix, Pittsburgh, Plano, Richmond, Saint Charles, San Antonio, San Diego, San Francisco, San Rafael, Spring, Staten Island, Stone Mountain, The Bronx, Virginia Gardens, West Chester, West Point, Worcester
- Age
- 5 years to 17 years
- People
- 400 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07424404 · EU 2025-524062-16-00 - No phaseNot yet taking people in United StatesDeep Brain Stimulation for Treatment-Resistant Schizophrenia
- Where
- Baltimore
- Age
- 22 years to 65 years
- People
- 15
- Run by
- Johns Hopkins University
See details and how to joinNCT07592611 - No phaseTaking peopleMI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMI
- Where
- West Los Angeles
- Age
- 18 years to 65 years
- People
- 50
- Run by
- VA Office of Research and Development
See details and how to joinNCT06138054 - No phaseTaking peopleREACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
- Where
- Cleveland
- Age
- 18 years to 50 years
- People
- 30
- Run by
- Case Western Reserve University
See details and how to joinNCT07006935 - Phase 3Taking peopleSafety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Where
- Anaheim, Atlanta, Avon Lake, Bellevue, Bloomfield Hills, Cincinnati, Colorado Springs, Coppell, Everett, Fort Myers, Fort Worth, Gainesville, Garden Grove, Garfield Heights, Hialeah, Homestead, Houston, Indianapolis, Jacksonville, Las Vegas, Lawrenceville, Lincoln, Little Rock, Miami, Miami Gardens, Miami Lakes, Naperville, Nashville, New York, Norman, Oceanside, Oklahoma City, Orlando, Phoenix, Plano, Pompano Beach, Redlands, Richmond, Sacramento, Saint Charles, San Diego, Savannah, Staten Island, St. Petersburg, West Covina, West Palm Beach
- Age
- 5 years to 17 years
- People
- 300 worldwide
- Run by
- Intra-Cellular Therapies, Inc.
See details and how to joinNCT06229210 · EU 2023-507068-38-00 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Where
- Anaheim, Bellevue, Bonita Springs, Brandon, Charlotte, Coral Springs, Cypress, Delray Beach, Doral, Homestead, Los Alamitos, Maitland, Matthews, Miami, Newport Beach, Orange, Orlando, San Antonio, Sarasota, Savannah, Tampa, Toms River, Walnut Creek
- Age
- 55 years and over
- People
- 370 worldwide
- Run by
- Intra-Cellular Therapies, Inc.
See details and how to joinNCT06540833 - Phase 1Taking peopleA Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Where
- Atlanta, Austin, Cedarhurst, Chicago, Garden Grove, Kalamazoo, Richardson, Staten Island
- Age
- 18 years to 60 years
- People
- 64
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07615426 - No phaseNot yet taking people in United StatesNEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia
- Where
- Minneapolis
- Age
- 18 years to 79 years
- People
- 168
- Run by
- University of Minnesota
See details and how to joinNCT07788755 - Phase 2Taking peopleStudy to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
- Where
- Little Rock, Richardson
- Age
- 18 years to 60 years
- People
- 60
- Run by
- TG Therapeutics, Inc.
See details and how to joinNCT07680946 - Phase 3Taking peopleRelapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Where
- Anaheim, Atlanta, Austin, Bellflower, Bentonville, Boynton Beach, Chicago, Cincinnati, Culver City, Gaithersburg, Garden Grove, Hollywood, La Habra, Lemon Grove, Little Rock, Miami, Miami Lakes, Miami Springs, Montclair, Oakland Park, Oklahoma City, Orange, Pico Rivera, Redlands, Richardson, Riverside, Rogers, Sandy Springs, Savannah, Torrance
- Age
- 18 years to 65 years
- People
- 472 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07686263 · EU 2025-523664-20-00 - No phaseTaking peopleDeveloping Biomarker-Supported Schizophrenia Spectrum Disorder (SSD) Prevention
- Where
- Houston
- Age
- 9 years to 26 years
- People
- 100
- Run by
- The University of Texas Health Science Center, Houston
See details and how to joinNCT07743645 - No phaseNot yet taking people in United StatesReducing Stigma - A Treatment for Early Psychosis to Prevent Suicide
- Where
- Providence
- Age
- 15 years to 25 years
- People
- 35
- Run by
- Butler Hospital
See details and how to joinNCT07898631